USPTO granted Kurin an Ex Parte request to reexamine U.S. Patent No. 10,039,483 that is asserted by Magnolia Medical in patent litigation.

SAN DIEGO-- (BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of Kurin ® blood culture collection sets, announced record revenues for the first quarter of 2024, following a record 2023.

SAN DIEGO, June 03, 2025--The synergy between Kurin's technology and Crouse Hospital's dedication to excellence sets a new standard for managing contaminated blood cultures.

Kurin and Crouse Hospital: A Transformative Partnership in Reducing Contaminated Blood Cultures Provided by Business Wire Jun 3, 2025, 3:00:00 AM ...